Related Experiment Video
Updated: Sep 7, 2025

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
Published on: September 21, 2021
Pediatric heart transplantation: The past, the present, and the future
Jason W Greenberg1, Amalia Guzman-Gomez2, Spencer Hogue2
1The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Ave, Cincinnati, Ohio, 45229..
Insights
Pediatric heart transplantation (HTx) has advanced significantly, with survival now measured in decades due to improved immunosuppression and care. Future innovations aim to further enhance outcomes for children needing heart transplants.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Transplantation Medicine
Background:
- Heart transplantation (HTx) has evolved from early 20th-century origins to become a life-saving procedure for pediatric patients.
- The first pediatric orthotopic heart transplant occurred in 1967 for a neonate with Ebstein anomaly.
- Currently, around 500 pediatric HTx procedures are performed annually worldwide.
Purpose of the Study:
- To review the historical progression and current status of pediatric heart transplantation.
- To highlight key advancements contributing to improved patient survival and outcomes.
- To discuss future directions and innovations in the field of pediatric HTx.
Main Methods:
- Historical review of heart transplantation milestones.
- Analysis of current pediatric heart transplant statistics.
- Discussion of advancements in medical and surgical care, including immunosuppression and mechanical support.
Main Results:
- Pediatric heart transplant survival has dramatically improved, with outcomes now measured in decades.
- Significant reductions in waitlist mortality and post-transplant complications have been achieved.
- Key factors include advances in immunosuppression, critical care, specialized transplant teams, and mechanical circulatory support.
Conclusions:
- Pediatric heart transplantation has transitioned from experimental to a standard, highly successful therapy.
- Ongoing research focuses on developing novel intracorporeal ventricular assist devices (VADs) for pediatric use.
- Future advancements include expanding donor criteria and exploring xenotransplantation to address organ shortages.
Abstract:
Heart transplantation (HTx) has a storied past, with origins dating back to the early twentieth century and the first pediatric orthotopic heart transplant performed in 1967 on a neonate with Ebstein abnormality. Today, approximately 500 pediatric HTx are performed annually, with survival times now measured in decades rather than days or weeks. In large part, advances in immunosuppression, critical care, dedicated transplant teams and mechanical circulatory support have paved the way for improvements in waitlist mortality and post-transplant survival, with future directions including the development of intracorporeal ventricular assist devices (VADs) for small children, expanding/standardizing donor criteria, and xenotransplantation.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care

